|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2723 USD | -0.26% |
|
-13.28% | -21.26% |
EPS & Dividend: Virax Biolabs Group Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -3.36 | -1.62 | -0.4 | -0.24 |
| Distribution rate | - | - | - | - |
| Reference price 2 | 0.7170 | 1.1400 | 0.2723 | 0.2723 |
| Nbr of stocks (in thousands) | 2,362 | 4,342 | 7,423 | - |
| Announcement Date | 20/08/24 | 02/07/25 | - | - |
1USD in Million2USD
Estimates
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| - | - | -0.68x | - | - | ||
| 0.88% | 1.01% | 38.6x | 3.98x | 5.61x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 33.64x | 6.41x | 3.34x | ||
| -.--% | -.--% | 103.66x | 9.38x | 6.64x | ||
| 0.35% | 0.36% | 54.92x | 2.63x | 11.26x | ||
| -.--% | -.--% | -21.27x | 14.47x | 6171.3x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | 40.96x | 40.89x | 6.64x | ||
| - | - | - | - | - | ||
| Average | 0.21% | 0.23% | 35.69x | 12.96x | 1,034.13x | |
| Weighted average by Cap. | 0.27% | 0.31% | 45.70x | 9.67x | 719.20x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















